Cargando…

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1

BACKGROUND: Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder, predisposing development of benign and malignant tumours. Given the oncogenic potential, long-term surveillance is important in patients with NF1. Proposals for NF1 care and its specific manifestations have been developed,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carton, Charlotte, Evans, D. Gareth, Blanco, Ignacio, Friedrich, Reinhard E., Ferner, Rosalie E., Farschtschi, Said, Salvador, Hector, Azizi, Amedeo A., Mautner, Victor, Röhl, Claas, Peltonen, Sirkku, Stivaros, Stavros, Legius, Eric, Oostenbrink, Rianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845795/ https://www.ncbi.nlm.nih.gov/pubmed/36684394 http://dx.doi.org/10.1016/j.eclinm.2022.101818

Ejemplares similares

ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis
por: Evans, D. Gareth, et al.
Publicado: (2022)

Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline
por: Kratz, Christian Peter, et al.
Publicado: (2021)

Identifying challenges in neurofibromatosis: a modified Delphi procedure
por: Dhaenens, Britt A. E., et al.
Publicado: (2021)

Craniofacial and oral alterations in patients with Neurofibromatosis 1
por: Visnapuu, Vivian, et al.
Publicado: (2018)

Non-optic glioma in adults and children with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2017)

Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients
por: Farschtschi, Said, et al.
Publicado: (2016)

Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Author Correction: Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
por: Well, Lennart, et al.
Publicado: (2021)

Increased risk for dementia in neurofibromatosis type 1
por: Kallionpää, Roope A., et al.
Publicado: (2021)

MRI based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools
por: Kollmann, Philipp, et al.
Publicado: (2020)

Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

A rare disease and education: Neurofibromatosis type 1 decreases educational attainment
por: Johansson, Edvard, et al.
Publicado: (2021)

Neurofibromatosis type 1 of the child increases birth weight
por: Leppävirta, Jussi, et al.
Publicado: (2019)

Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study
por: Evans, D. Gareth R., et al.
Publicado: (2019)

Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2018)

Intestinal tumors in neurofibromatosis 1 with special reference to fatal gastrointestinal stromal tumors (GIST)
por: Ylä‐Outinen, Heli, et al.
Publicado: (2019)

Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation
por: Farschtschi, Said, et al.
Publicado: (2015)

Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth
por: Well, Lennart, et al.
Publicado: (2021)

Long-term Follow-up and Histological Correlation of Peripheral Nervous System Alterations in Neurofibromatosis Type 2
por: Godel, Tim, et al.
Publicado: (2021)

Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study
por: Leppävirta, Jussi, et al.
Publicado: (2018)

The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1
por: Well, Lennart, et al.
Publicado: (2020)

Examination of the genetic factors underlying the cognitive variability associated with neurofibromatosis type 1
por: Ottenhoff, Myrthe J., et al.
Publicado: (2020)

Pediatric malignancies in neurofibromatosis type 1: A population‐based cohort study
por: Peltonen, Sirkku, et al.
Publicado: (2019)

Reliability of functional outcome measures in adults with neurofibromatosis 1
por: Mullin, Rebecca L, et al.
Publicado: (2018)

Neuroanatomical correlates of working memory performance in Neurofibromatosis 1
por: Sawyer, Cameron, et al.
Publicado: (2022)

Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage
por: Kurtelius, Arttu, et al.
Publicado: (2017)

Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors
por: Uusitalo, Elina, et al.
Publicado: (2017)

Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1
por: Ristow, Inka, et al.
Publicado: (2022)

Legius Syndrome and its Relationship with Neurofibromatosis Type 1
por: DENAYER, Ellen, et al.
Publicado: (2020)

Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future
por: Reilly, Karlyne M., et al.
Publicado: (2017)

Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1
por: Garg, Shruti, et al.
Publicado: (2022)

Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2
por: Ferner, Rosalie E., et al.
Publicado: (2014)

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
por: Byrne, Susan, et al.
Publicado: (2017)

Resection of small plexiform neurofibromas in neurofibromatosis type 1 children
por: Friedrich, Reinhard E, et al.
Publicado: (2005)

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET
por: Cook, Gary J. R., et al.
Publicado: (2017)

Introduction to Endo-ERN–scope and mission
por: Pereira, Alberto M., et al.
Publicado: (2021)

The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis
por: Kehrer-Sawatzki, Hildegard, et al.
Publicado: (2016)

Motor problems in children with neurofibromatosis type 1
por: Rietman, André B., et al.
Publicado: (2017)

The effect of post-injection (18)F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
por: Lovat, Eitan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e3bmt18p82vhnsauavnhrl4mj9